AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $254,000 | -86.7% | 8,986 | -84.5% | 0.03% | -85.8% |
| Q4 2021 | $1,908,000 | +210.7% | 58,059 | +230.8% | 0.24% | +135.3% |
| Q3 2020 | $614,000 | +61.2% | 17,552 | +49.2% | 0.10% | +96.2% |
| Q3 2019 | $381,000 | +1.6% | 11,764 | +56.3% | 0.05% | +23.8% |
| Q2 2019 | $375,000 | +43.1% | 7,528 | +121.4% | 0.04% | +200.0% |
| Q3 2018 | $262,000 | +18.6% | 3,400 | +8.5% | 0.01% | +27.3% |
| Q3 2015 | $221,000 | -81.5% | 3,134 | -70.8% | 0.01% | -76.1% |
| Q2 2015 | $1,193,000 | -59.7% | 10,734 | -65.8% | 0.05% | -61.0% |
| Q1 2015 | $2,958,000 | – | 31,367 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |